NV
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
1.906
Exchange
XNAS - Nasdaq
0.95 B
Last period Cash and equivalents ,USD
234%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Novocure
Company Analysis
NVCR valuation, rating, competitors, insights and company profile
Eyestock Rating
NVCR financial analysis by Eyestock methodology
Valuation
NVCR valuation using historical relative method
Statements
NVCR Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NVCR dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Novocure`s Cash and equivalents for the period ended 2024-06-30 are 0.95 B USD
